HomeARTV • NASDAQ
add
Artiva Biotherapeutics Inc
Previous close
$10.26
Day range
$9.30 - $10.18
Year range
$9.30 - $17.31
Market cap
227.11M USD
Avg Volume
59.32K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Sep 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 18.34M | 15.71% |
Net income | -17.47M | -254.91% |
Net profit margin | — | — |
Earnings per share | -0.87 | — |
EBITDA | -17.71M | -255.78% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Sep 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 146.63M | — |
Total assets | 225.60M | — |
Total liabilities | 24.60M | — |
Total equity | 201.00M | — |
Shares outstanding | 24.29M | — |
Price to book | 1.24 | — |
Return on assets | -30.41% | — |
Return on capital | -35.66% | — |
Cash Flow
Net change in cash
(USD) | Sep 2024info | Y/Y change |
---|---|---|
Net income | -17.47M | -254.91% |
Cash from operations | -11.61M | -8.03% |
Cash from investing | -130.63M | -26,396.55% |
Cash from financing | 163.87M | 599.38% |
Net change in cash | 21.63M | 77.47% |
Free cash flow | -7.24M | — |
About
Founded
2019
Website
Employees
82